Ethanol

Acelen Renewables Selects Honeywell for SAF and Renewable Diesel Fuel Production

Retrieved on: 
Wednesday, January 24, 2024
Diamond, CO2, Fuel oil, TotalEnergies, Air travel, Oil, Carbon dioxide, SAF, Ethanol, European Council, Plant, BP, GHG, Growth, Renewable energy

CHARLOTTE, N.C., Jan. 24, 2024 /PRNewswire/ -- Honeywell (Nasdaq: HON) announced that Acelen Renewables has selected its Ecofining™ technology to help support the efficient production of a targeted 20,000 barrels per day of sustainable aviation fuel (SAF) and renewable diesel. The fuels will be processed at Acelen's facility in Bahia, Brazil, from a blend of inedible seed and waste oils. With this agreement, Acelen Renewables becomes the 50th site to license Honeywell's renewable fuels technology.

Key Points: 
  • CHARLOTTE, N.C., Jan. 24, 2024 /PRNewswire/ -- Honeywell (Nasdaq: HON) announced that Acelen Renewables has selected its Ecofining™ technology to help support the efficient production of a targeted 20,000 barrels per day of sustainable aviation fuel (SAF) and renewable diesel.
  • With this agreement, Acelen Renewables becomes the 50th site to license Honeywell's renewable fuels technology.
  • Honeywell's Ecofining process, which was developed in collaboration with Eni SpA, offers a capital- and cost-effective solution for processing waste fats, oils and greases into renewable diesel and SAF.
  • Acelen Renewables joins a roster of companies around the world currently licensing Honeywell's renewable fuels technology, including BP, CVR Energy, Diamond Green Diesel, Eni, Repsol, Total Energies, and World Energy.

Alternative Fuels Market to Record a Growth of USD 78.41 billion between 2022 and 2027, Discover Latest Trends, Market Share, and Evolving Opportunities - Technavio

Retrieved on: 
Monday, January 22, 2024
Fuel oil, Chevron Corporation, PJSC, Natural gas, Aviation, Shell plc, Honeywell, CNOOC, ENGIE, Gazprom, World Bank, Equinor, Growth, Sale, Petrobras, Carbon, Climate change, PEM, USD, Ethanol, OMV, Professional corporation, BP, Gevo, Greenhouse gas, Methanol, GHG, ExxonMobil, Renewable energy

NEW YORK, Jan. 22, 2024 /PRNewswire/ -- The alternative fuels market size is expected to grow by USD 78.41 billion from 2022 to 2027, according to Technavio.

Key Points: 
  • NEW YORK, Jan. 22, 2024 /PRNewswire/ -- The alternative fuels market size is expected to grow by USD 78.41 billion from 2022 to 2027, according to Technavio.
  • The Alternative Fuels Market is witnessing a significant uptrend driven by the escalating adoption of eco-friendly fuel sources in the transportation sector.
  • The global off-grid alternative fuels market is expected to grow rapidly during the forecast period due to the Increasing emissions of GHGs.
  • These strategic investments are poised to propel the growth of the alternative fuels market in the APAC region throughout the forecast period.

ClearFlame Engine Technologies Sells First Truck to Vander Haag's Inc.

Retrieved on: 
Wednesday, January 17, 2024
Paris Agreement, EVS, Temperature, Aircraft, Sale, Carbon, EV, Ethanol, Growth, Renewable energy

GENEVA, Ill., Jan. 17, 2024 /PRNewswire/ -- ClearFlame Engine Technologies announced today that it has completed the first sale of its FuelAdaptive™ truck to Vander Haag's Inc. The truck is the world's first product to deliver diesel-like performance to the heavy-duty trucking industry with a reduction in fuel costs and carbon emissions using a nationally-distributed fuel.

Key Points: 
  • GENEVA, Ill., Jan. 17, 2024 /PRNewswire/ -- ClearFlame Engine Technologies announced today that it has completed the first sale of its FuelAdaptive™ truck to Vander Haag's Inc.
  • Vander Haag's, a leader in sustainable heavy-duty solutions, will use ClearFlame's truck to deliver parts to its 11 locations in multiple states.
  • More than 40 percent lower fuel costs than diesel: ClearFlame's FuelAdaptive™ engine is the only alternative fuel engine technology in the market that offers the same performance as a diesel engine with lower fuel costs.
  • "Vander Haag's has been an enthusiastic development partner for ClearFlame because of their market readiness, cost savings and use of existing infrastructure.

Autonomix Medical, Inc. Successfully Completes Preclinical Safety Study to Support Program Advancement into First-in-Human Clinical Study to Treat Pancreatic Cancer Pain Through Transvascular Ablation

Retrieved on: 
Friday, January 12, 2024
Entrepreneurship, RF, Pain management, Human, Safety, Ethanol, Pain, Observation, Nervous system, Trial of the century, Pharmaceutical industry

THE WOODLANDS, TX, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced successful completion of an animal safety study evaluating the Company’s proprietary ablation technology. All safety inputs for the study were met. No procedure-related side effects have been reported.

Key Points: 
  • The safety study was designed to assess acute safety and feasibility of tissue ablation in a porcine multi-arterial model.
  • Findings in the study demonstrated successful energy delivery, with no acute complications using several of the Company’s proprietary ablation catheters.
  • “We are very pleased with the outcome of this important safety study, and we continue to execute on developing our potentially groundbreaking technology.
  • The successful completion of this preclinical safety study provides us with supportive data as we advance toward our first-in-human clinical study, a catalytic milestone for Autonomix,” commented Lori Bisson, Chief Executive Officer of Autonomix.

India $10.45 Billion Ethanol Market Competition Forecast & Opportunities, 2029F - Supportive Government Policies and Increasing Demand for Biofuels for Sustainable Development

Retrieved on: 
Thursday, January 11, 2024
Weather, CO2, Farmer, Ethanol, Temperature, Investment, Biofuel, Knowledge, Government, Biomass, Carbon, E20, Climate change, Fossil, Water, Urbanization, Pressure, USD, Running, Transport, Private sector, EBP, Air pollution, Compound annual growth rate, Growth, Renewable energy

These factors collectively contribute to the expansion of the India Ethanol Market in the forecast period.

Key Points: 
  • These factors collectively contribute to the expansion of the India Ethanol Market in the forecast period.
  • The escalating demand for biofuels, specifically ethanol, aligns with India's pursuit of sustainable development, representing a fundamental shift in the country's energy landscape.
  • The Indian government has also introduced initiatives and policies to promote ethanol use in the automotive industry, further propelling ethanol demand.
  • These factors collectively underscore the increasing demand from the automotive sector, thereby driving the India Ethanol Market's growth during the forecast period.

Smart Carbon Ethanol Market Analysis 2023-2033, Featuring Key Player Analysis for ArcelorMittal, Baosteel, Gevo, LanzaTech, MaireTecnimont, Steelanol & Swayana

Retrieved on: 
Thursday, January 4, 2024
Carbon, Growth, Ethanol, Policy, Rest, Projection, Climate change, Renewable energy

DUBLIN , Jan. 4, 2024 /PRNewswire/ -- The "Smart Carbon Ethanol Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN , Jan. 4, 2024 /PRNewswire/ -- The "Smart Carbon Ethanol Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The global smart carbon ethanol market is experiencing significant growth as the world intensifies efforts to combat climate change and transition towards more sustainable energy solutions.
  • The growth of the smart carbon ethanol market is closely tied to increasing awareness and recognition of the urgent need for sustainable energy practices.
  • The transportation sector, a significant contributor to carbon emissions, is particularly focused on adopting cleaner alternatives, making smart carbon ethanol an attractive option.

Autonomix Medical, Inc. Provides Business Overview and Highlights Upcoming Milestones

Retrieved on: 
Thursday, January 4, 2024
Quality of life, Pain, Disease, Clinical trial, IP, Nervous system, Electrophysiology, Ethanol, Patient, Collateral damage, Medical imaging

THE WOODLANDS, TX, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today provided a business overview and highlighted upcoming milestones.

Key Points: 
  • THE WOODLANDS, TX, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today provided a business overview and highlighted upcoming milestones.
  • Lori Bisson, Chief Executive Officer of Autonomix, commented, “Autonomix is dedicated to dramatically improving the quality of millions of lives by empowering the nerve-directed treatments of tomorrow.
  • Achieving “proof-of-concept” in this area could open the door to blockbuster diseases, expanding the horizons for the Company’s technology.
  • The smaller and shorter clinical trials potentially translate to more efficient resource utilization, minimizing overall development costs.

Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases

Retrieved on: 
Thursday, January 4, 2024
FDA, Health, Clinical Trials, Pharmaceutical, Optical, Biotechnology, Alcoholism, Atopic dermatitis, Cholesterol, Metabolism, Multimedia, IND, Alcoholic hepatitis, Disease, Mortality, AMD, Body surface area, Therapy, MELD, Clinical trial, Hospital, Telecanthus, DSM-IV codes, Spasticity, Protocol, Cirrhosis, Biomarker, Triglyceride, Syndrome, Ethanol, Patient, Safety, RASP, Retina, Pharmaceutical industry

ADX-629, administered twice daily over 90 days, has completed initial clinical testing in three adult patients in an investigator-sponsored clinical trial.

Key Points: 
  • ADX-629, administered twice daily over 90 days, has completed initial clinical testing in three adult patients in an investigator-sponsored clinical trial.
  • Highlighting the advancement of the RASP platform and the selection of key clinical indications for future development, Aldeyra released a focused pipeline.
  • “With the success achieved in our ADX-629 program, which includes a number of positive, signal-finding clinical results, we are excited to advance our RASP modulator pipeline to systemic and retinal immune-mediated diseases, as well as metabolic diseases, exacerbated by RASP,” stated Dr. Brady.
  • “We anticipate 2024 to provide a variety of clinical-stage catalysts, as Aldeyra continues to progress its novel RASP platform.”

Third Generation Family Member, Natalie Morhous, Promoted to Chief Executive Officer of RaceTrac, Inc.

Retrieved on: 
Wednesday, January 3, 2024
Gulf Oil, RaceTrac, Putting People First, Acquisition, News, Engineering, Culture, Growth, Ethanol, Management

Since assuming their respective positions as CEO and president in 2019, McBrayer and Morhous have partnered on RaceTrac’s business decisions and strategy development.

Key Points: 
  • Since assuming their respective positions as CEO and president in 2019, McBrayer and Morhous have partnered on RaceTrac’s business decisions and strategy development.
  • “The board is thrilled to share the news that Natalie Morhous will be assuming the role of chief executive officer,” said Max Lenker, a board director at RaceTrac.
  • In 2014, McBrayer became chief supply officer before assuming his most recent role as CEO.
  • Prior to joining the company, Natalie worked as a consultant with SRA Touchstone Consulting Group and Acquisition Solutions, Inc.

Agrify Corporation Announces Results for Third Quarter 2023

Retrieved on: 
Wednesday, January 3, 2024
Ethanol, Science, Operating cost, ROI, Rare-earth element

TROY, Mich., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced financial results for the third quarter ended September 30, 2023 (“Q3 2023”).

Key Points: 
  • TROY, Mich., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced financial results for the third quarter ended September 30, 2023 (“Q3 2023”).
  • The team remains committed to turn the business profitable in the shortest time possible.”
    Revenue was $3.1 million for Q3 2023, compared to $7.0 million for Q3 2022.
  • Gross profit was $1.0 million for Q3 2023, compared to a loss of $(4.1) million in Q3 2022.
  • Operating loss was $(4.6) million for Q3 2023, compared to an operating loss of $(31.5) million for Q3 2022.